Bares Capital Management BMY trades
Brian Bares
Bares Capital Management Bristol-Myers Squibb Company stake
total: 156
Trades details
- Total transactions:
- 4
- New positions:
- 2
- Sold out:
- 2
- Held since:
- 2014 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q1
According to 2025 Q3 report, Bares Capital Management doesn't hold any Bristol-Myers Squibb Company (BMY) shares. To date, the estimated cost basis is nearly $58.95 for "buy" trades and estimated average "sell" price is $58.95. Bares Capital Management first purchased BMY in 2013 Q4, initially acquiring 3,834 shares. Bares Capital Management later completely sold out the position and invested in Bristol-Myers Squibb Company again in 2014 Q4. Since the initial investment in Bristol-Myers Squibb Company (BMY), Bares Capital Management has made 3 more transactions.
When did Bares Capital Management sell Bristol-Myers Squibb Company (BMY)?
Bares Capital Management sold off the entire Bristol-Myers Squibb Company (BMY) position in 2015 Q1.
When did Bares Capital Management buy Bristol-Myers Squibb Company (BMY)?
Bares Capital Management first invested in Bristol-Myers Squibb Company (BMY) in 2013 Q4 at the reported quarter-end price of $53.21 per share.
What's the cost basis of Bares Capital Management's BMY stake?
The estimated cost basis for Bristol-Myers Squibb Company (BMY) stake is around $58.95 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $58.95
- Weighted AVG sell price:
- $58.95
Bares Capital Management's historical trades in Bristol-Myers Squibb Company
4 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2015 Q1
|
0.00%
|
$58.95
|
-100% (-3,834)
|
|||
|
2014 Q4
|
0.03%
|
$58.95
|
new
|
|||
|
2014 Q1
|
0.00%
|
$53.21
|
-100% (-3,834)
|
|||
|
2013 Q4
|
0.02%
|
$53.21
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.